---
figid: PMC5594453__12943_2017_720_Fig3_HTML
figlink: /pmc/articles/PMC5594453/figure/Fig3/
number: Fig. 3
caption: The signaling pathways that are activated by TMEM16A in cancer. TMEM16A directly
  interacts with EGFR [], and promotes EGFR phosphorylation, which activates the AKT/SRC/ERK1/2
  signaling []. In addition, TMEM16A increases autocrine secretion of EGF in breast
  cancer cells []. TMEM16A directly interacts with IP3R, and increased Ca2+ release
  from the ER []. TMEM16A activates CaMKII by increasing intracellular Ca2+ concentrations,
  and CaMKII subsequently activates the AKT/SRC/ERK1/2 signaling []. TMEM16A also
  activates the Ras-Raf-Mek-ERK1/2 signaling pathway in UM-SCC1 HNSCC cells and T24
  bladder cells []. In SMMC-7721 human hepatoma cells, TMEM16A activates the p38 signaling
  pathway []. TMEM16A activates the NFκB signaling pathway and promotes the gene transcription
  in glioma cells []. +, activates the signaling pathway.?, the mechanisms of how
  TMEM16A activates the signaling pathway are unknown
pmcid: PMC5594453
papertitle: Cell-specific mechanisms of TMEM16A Ca2+-activated chloride channel in
  cancer.
reftext: Hui Wang, et al. Mol Cancer. 2017;16:152.
pmc_ranked_result_index: '1288'
pathway_score: 0.9709136
filename: 12943_2017_720_Fig3_HTML.jpg
figtitle: Signaling pathways that are activated by TMEM16A in cancer
year: '2017'
organisms: Homo sapiens
ndex: b6d03cf7-dec7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5594453__12943_2017_720_Fig3_HTML.html
  '@type': Dataset
  description: The signaling pathways that are activated by TMEM16A in cancer. TMEM16A
    directly interacts with EGFR [], and promotes EGFR phosphorylation, which activates
    the AKT/SRC/ERK1/2 signaling []. In addition, TMEM16A increases autocrine secretion
    of EGF in breast cancer cells []. TMEM16A directly interacts with IP3R, and increased
    Ca2+ release from the ER []. TMEM16A activates CaMKII by increasing intracellular
    Ca2+ concentrations, and CaMKII subsequently activates the AKT/SRC/ERK1/2 signaling
    []. TMEM16A also activates the Ras-Raf-Mek-ERK1/2 signaling pathway in UM-SCC1
    HNSCC cells and T24 bladder cells []. In SMMC-7721 human hepatoma cells, TMEM16A
    activates the p38 signaling pathway []. TMEM16A activates the NFκB signaling pathway
    and promotes the gene transcription in glioma cells []. +, activates the signaling
    pathway.?, the mechanisms of how TMEM16A activates the signaling pathway are unknown
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ARAF
  - RELB
  - MAPK13
  - MAPK12
  - EGF
  - EGFR
  - MAPK14
  - MAPK11
  - CAMK2B
  - RELA
  - ANO1
  - AKT3
  - AKT1
  - REL
  - SRC
  - NFKB1
  - MAPK1
  - RAF1
  - BRAF
  - MAPK3
  - MAP2K2
  - AKT2
  - NFKB2
  - NRAS
  - HRAS
  - KRAS
  - MAP2K1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: EĞF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: CAMKII
  symbol: CAMK2
  source: hgnc_alias_symbol
  hgnc_symbol: CAMK2B
  entrez: '816'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: TMEM16A
  symbol: TMEM16A
  source: hgnc_prev_symbol
  hgnc_symbol: ANO1
  entrez: '55107'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: SRC
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
